
SLRX Stock Forecast & Price Target
SLRX Analyst Ratings
Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%
SLRX has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Salarius Pharmaceuticals Inc and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Salarius Pharmaceuticals Inc and is not a guaranteed prediction by Public.com or investment advice.
SLRX Analyst Forecast & Price Prediction
Get the latest SLRX stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in SLRX
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Salarius Pharmaceuticals Inc (SLRX) Forecast
Analysts have given SLRX a Buy based on their latest research and market trends.
According to 2 analysts, SLRX has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $4.50, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $4.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.